Market Overview

Illumina's Q4 Earnings Outlook


On Tuesday, Jan. 29, Illumina (NASDAQ: ILMN) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release.

Earnings and Revenue

Illumina EPS will likely be near $1.36 while revenue will be around $862.42 million, according to analysts.

Illumina earnings in the same period a year ago was $1.44 and quarterly sales came in at $778 million. If the company were to match the consensus estimate when it reports Tuesday, EPS would have fallen 5.56 percent. Revenue would be up 10.85 percent from the year-ago period. Here's how the company's reported EPS has compared to analyst estimates in the past:


Quarter Q3 2018 Q2 2018 Q1 2018 Q4 2017
EPS Estimate 1.26 1.11 1.01 1.18
EPS Actual 1.52 1.43 1.45 1.44

Stock Performance

Over the last 52-week period, shares are up 21.19 percent. Given that these returns are generally positive, long-term shareholders are probably content going into this earnings release. Over the past 90 days, analysts have generally adjusted their estimates lower for EPS and revenues. The average rating by analysts on Illumina stock is a Neutral. The validity of this rating has maintained conviction over the past 90 days.

Conference Call

Illumina is scheduled to hold a conference call at 5:00 p.m. ET and it can be accessed here:

Posted-In: Earnings News


Related Articles (ILMN)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive

Advanced Micro Devices Q4 Earnings Preview